Advertisement

Topics

Latest "SC Johnson" News Stories

07:52 EDT 17th October 2018 | BioPortfolio

Here are the most relevant search results for "SC Johnson" found in our extensive news archives from over 250 global news sources.

More Information about SC Johnson on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about SC Johnson for you to read. Along with our medical data and news we also list SC Johnson Clinical Trials, which are updated daily. BioPortfolio also has a large database of SC Johnson Companies for you to search.

Showing "Johnson" News Articles 1–25 of 1,300+

Wednesday 17th October 2018

Adhesive Innovation Helps Clinicians Confidently Meet the Most Challenging Demands of Critical Tube Securement

New 3M™ Durapore™ Advanced Surgical Tape provides exceptional adhesion to meet clinicians’ securement needs One of the most important, yet stressful jobs clinicians do is to ensure critical, life-sustaining tubes are safely secured because even the slightest millimeter of movement can be life-threatening for some patients. While recent adhesive a...


Global NOx Adsorbers Market Status and Outlook 20182025 [Report Updated: 13082018] Prices from USD $4000

Report SnapshotKey Content of Chapters Including and can be customized, report is a semifinished version, and it takes 4872 hours to upgradePart 1:Terminology Definition, Industry Chain,Industry Dynamics Regulations and Global Market OverviewPart 2:Upstream Raw Materials / Components Manufacturing Procurement Methods Channels and Cost , Major Regional Production Overview and Trade FlowPart 3:Pr...

Tuesday 16th October 2018

J&J's Baby, Beauty Sectors Boost Consumer Health Sales Rebound

Johnson’s baby product sales picked up in the third quarter after a rough start as its baby care division sales...  


J&J beats profit estimates, lifts outlook on pharma unit strength

Johnson & Johnson reported slightly better-than-expected third quarter profit and raised its full-year forecast on Tuesday as increased demand for cancer drugs and immune disorder treatments powered strong results for its pharmaceutical unit.

Genmab Announces Net Sales of DARZALEX (daratumumab) for Third Quarter of 2018

Genmab (Nasdaq:GEN) announced today that worldwide net sales of DARZALEX (daratumumab) as reported by Johnson & Johnson were USD 498 million in the third quarter of 2018 compared to USD 317 million in the third quarter of 2017, an increase of 57%. As quoted in the press release: The 2018 third quarter net sales were … Continued The post Genmab Announces Net Sales of DARZALEX (daratumumab...

J&J applauds U.S. proposal on drug prices in TV ads

Johnson & Johnson applauded a U.S. government proposal requiring drugmakers to include price of medicines in television ads, Chief Financial Officer Joseph Wolk said in a CNBC interview on Tuesday.

Johnson & Johnson (JNJ) Q3 2018 Results - Earnings Call Transcript

Global Interactive Wound Dressing Market Status and Outlook 20182025 [Report Updated: 14082018] Prices from USD $4000

Report SnapshotKey Content of Chapters Including and can be customized, report is a semifinished version, and it takes 4872 hours to upgradePart 1:Terminology Definition, Industry Chain,Industry Dynamics Regulations and Global Market OverviewPart 2:Upstream Raw Materials / Components Manufacturing Procurement Methods Channels and Cost , Major Regional Production Overview and Trade FlowPart 3:Pr...

Goldman belässt Bayer auf 'Buy' - Ziel 111 Euro

Die US-Investmentbank Goldman Sachs hat Bayer nach Quartalszahlen von Konkurrent Johnson & Johnson auf "Buy" mit einem Kursziel von 111 Euro belassen. Der amerikanische Pharmakonzern habe zwar mit...

Johnson & Johnson edges past profit estimates, lifts outlook https://reut.rs/2CLroO9 

Johnson & Johnson edges past profit estimates, lifts outlook https://reut.rs/2CLroO9 

Johnson & Johnson edges past profit estimates, lifts outlook

Johnson & Johnson reported slightly better-than-expected quarterly profit on Tuesday and pushed its full-year forecast higher, as demand for its cancer drugs Zytiga and Imbruvica helped offset falling sales of arthritis treatment Remicade.

Johnson & Johnson profit beats, lifts forecast on cancer drug demand https://reut.rs/2CNLE1x 

Johnson & Johnson profit beats, lifts forecast on cancer drug demand https://reut.rs/2CNLE1x 

J&J agrees with U.S. proposal on drug prices in TV ads

Johnson & Johnson agreed with a U.S. government proposal requiring drugmakers to include price of medicines in television ads, Chief Financial Officer Joseph Wolk said in a CNBC interview on Tuesday.

Johnson & Johnson profit beats, lifts forecast on cancer drug demand

Johnson & Johnson on Tuesday reported quarterly profit above estimates and raised its full-year forecast, as demand for its cancer drugs Zytiga and Imbruvica helped offset decline in sales of blockbuster drug, Remicade.

Johnson & Johnson lifts annual guidance as third-quarter sales, profit rise https://www.firstwordpharma.com/node/1597531  $JNJ

Johnson & Johnson lifts annual guidance as third-quarter sales, profit rise https://www.firstwordpharma.com/node/1597531  $JNJ

Johnson & Johnson third-quarter results beat estimates; raises guidance for 2018

Company's sterling performance relied on its pharmaceutical, consumer and medical device businesses

Global Conceal Install Fan Coil Market Status and Outlook 20182025 [Report Updated: 18082018] Prices from USD $4000

Report SnapshotKey Content of Chapters Including and can be customized, report is a semifinished version, and it takes 4872 hours to upgradePart 1:Terminology Definition, Industry Chain,Industry Dynamics Regulations and Global Market OverviewPart 2:Upstream Raw Materials / Components Manufacturing Procurement Methods Channels and Cost , Major Regional Production Overview and Trade FlowPart 3:Pr...

Monday 15th October 2018

Global Air Conditioning Damper Actuator Market Status and Outlook 20182025 [Report Updated: 18082018] Prices from USD $4000

Report SnapshotKey Content of Chapters Including and can be customized, report is a semifinished version, and it takes 4872 hours to upgradePart 1:Terminology Definition, Industry Chain,Industry Dynamics Regulations and Global Market OverviewPart 2:Upstream Raw Materials / Components Manufacturing Procurement Methods Channels and Cost , Major Regional Production Overview and Trade FlowPart 3:Pr...

Can Johnson & Johnson Rally After Earnings?

SC Johnson is One of the 2018 World's Best Workplaces

RACINE, Wis., Oct. 15, 2018 /PRNewswire/ -- SC Johnson today announces it has been named as one of the 25 World's Best Workplaces by the Read more...

Insera Therapeutics Awarded Competitive Grant From the National Science Foundation

Small Business Innovation Research Program Provides Seed Funding for R&D Insera Therapeutics, Inc., has been awarded a National Science Foundation (NSF) Small Business Innovation Research (SBIR) grant for $221,700 to conduct research and development (R&D) work on its flagship solution for ischemic stroke, which includes the CLEAR® Aspiration S...

Global Chemical Catalyst Market Status and Outlook 20182025 [Report Updated: 18082018] Prices from USD $4000

Report SnapshotKey Content of Chapters Including and can be customized, report is a semifinished version, and it takes 4872 hours to upgradePart 1:Terminology Definition, Industry Chain,Industry Dynamics Regulations and Global Market OverviewPart 2:Upstream Raw Materials / Components Manufacturing Procurement Methods Channels and Cost , Major Regional Production Overview and Trade FlowPart 3:Pr...

Bayer: Sollen Anleger wieder einsteigen?

von Sven Parplies, Euro am Sonntag Ein schwer kranker Mann gegen einen großen Konzern: Spontan dürfte die Sympathie eines unbeteiligten Betrachters aufseiten von Dewayne Johnson liegen. Der Mann ha...

ConvaTec announces resignation of chief executive as it issues profit warning

Former Johnson & Johnson chairman Rick Anderson has been appointed interim chief executive of ConvaTec

Visikol Machine Learning Digital Pathology Services for Drug Discovery

Visikol is leveraging its 3Screen™ digital pathology tools to assist pharmaceutical companies with shifting the paradigm of tissue analysis from a human-driven qualitative approach to a computer-driven quantitative approach. WHITEHOUSE STATION, N.J. (PRWEB) October 15, 2018 Since the inception of the microscope, researchers and clinicians have characterized tissues through the visualization of ...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks